EichorEICHOR
Location: Irvine Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Irvine

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part
Phase 1/Phase 2 · University of California - Irvine · AskBio Inc · NCT05230459A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Chao Family Comprehensive Cancer Center and Ambulatory Care · Eli Lilly and Company · NCT07218380Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Phase 3 · Joseph Broderick, MD · NCT07227246Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Phase 3 · Novartis Pharmaceuticals · NCT05755386This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · UCLA Hematology/Oncology - Irvine · Pfizer · NCT07028853Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
NA · University of California, Irvine · NCT06783751Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:
Phase N/A · Parkinson's Disease and Movement Disorders Center - Orange C · Supernus Pharmaceuticals, Inc. · NCT07219927MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · UCI Health - Chao Family Comprehensive Cancer Center and Amb · National Cancer Institute (NCI) · NCT05564390Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia
Phase 3 · Vanda Investigational Site · Vanda Pharmaceuticals · NCT06953869Telemedicine to Support Living Kidney Donor Candidates
NA · University of California, Irvine · NCT07206069Study of XB010 in Subjects With Solid Tumors
Phase 1 · City of Hope Orange County Lennar Foundation Cancer Center · Exelixis · NCT06545331Digital Health Intervention for Children With ADHD
NA · The Craig School · University of California, Riverside · NCT06456372A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Phase 3 · Axiom Research, Orange County · Kallyope Inc. · NCT07674654Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · NRG Oncology · NCT05624996Single-Center Eval of Clinical & Radiological Benefit AHCC in Combo W/ SOC Tx for HPV+ Pts W/ HNSCC
Phase 2 · University of California, Irvine · NCT06693323A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Phase 1 · Chao Family Comprehensive Cancer Center and Ambulatory Care · Seagen, a wholly owned subsidiary of Pfizer · NCT05208762Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized Myasthenia Gravis
Phase 1/Phase 2 · Novartis Pharmaceuticals · NCT06704269Effects of Mouthrinse on the Microbiome of the Oral Cavity and GI Tract
NA · Beckman Laser Institute and Medical Clinic · University of California, Irvine · NCT05603650A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
Phase 1 · University of California Irvine · Fate Therapeutics · NCT06308978A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Phase 1 · City of Hope at Irvine Lennar · Pfizer · NCT07090499Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Phase 1/Phase 2 · City of Hope at Irvine Lennar · Pfizer · NCT07421700Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Phase 3 · Clinical Study Site · Summit Therapeutics · NCT07228832A Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With New-onset Generalized Myasthenia Gravis
Phase 4 · argenx · NCT06909214Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally A
Phase 1/Phase 2 · UCI Health - Chao Family Comprehensive Cancer Center and Amb · National Cancer Institute (NCI) · NCT04172532Coordinating Outpatient bupreNorphiNe for Emergency Care and Continuing Treatment
NA · University of California Irvine Emergency Department · University of California, Davis · NCT07024498A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solut
Phase 2/Phase 3 · City of Hope at Orange County Lennar Foundation Cancer Cente · AbbVie · NCT06109272Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astr
Phase 1 · UCI Health - Chao Family Comprehensive Cancer Center and Amb · National Cancer Institute (NCI) · NCT06860594Acoustic and Electrical Stimulation for the Treatment of Tinnitus
NA · Hamid R. Djalilian · University of California, Irvine · NCT03511807Impact of Personality on Adherence to Tyrosine Kinase Inhibitor Therapy in Pts w/Chronic Myeloid Leukemia
Phase N/A · University of California, Irvine · NCT06229860Decolonization to Reduce After-Surgery Events of Surgical Site Infection
Phase 4 · University of California, Irvine · NCT05586776
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.